Rifat Hasina

Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma.

Gene expression levels in different stages of progression in oral squamous cell carcinoma.

Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.

Classification and identification of genes associated with oral cancer based on gene expression profiles. A preliminary study.

Head and neck cancer: the pursuit of molecular diagnostic markers.

Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.

ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.

CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.

Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.

Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.

The role of the c-Met pathway in lung cancer and the potential for targeted therapy.